Sponsored by:
Facebook (FB)
JP Morgan (JPM)
AutoZone (AZO)
Yahoo (YHOO)
Focus Stocks
Featured Stories
Medtronic Reports Fourth Quarter Earnings
Cracker Barrel Reports Earnings, Increases Guidance
Best ETFs For Facebook Exposure
Is Yum! Brands Closing in to Support?
Intuitive Surgical Bullish Signs
Warner Chilcott to Present at the 30th Annual J.P. Morgan Healthcare Conference
Published on Wednesday, 04 January 2012 14:35 Written by TradersHuddle Staff
DUBLIN, Ireland, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its President, Europe/International and Global Marketing, Hans Van Zoonen, and its Executive Vice President and Chief Financial Officer, Paul Herendeen, are scheduled to speak at the 30th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10th at 8:30 a.m. PST (11:30 a.m. EST).
The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.
The Company
Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G
CONTACT: Company Contact:
Emily Hill
Investor Relations
973-907-7084
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Related Articles
- NASDAQ 100's Top Performers: CTRP, ADSK, FLEX
- Candlesticks - Bearish Engulfing Warner Chilcott
- Warner Chilcott: Ready for some Upside?
- NASDAQ 100's Update, In focus: MU, WCRX, GENZ, FSLR, BRCM
- Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2012
- Are the Bears Taking Control over Warner Chilcott?
- Announcement Under Irish Takeover Rules Relevant Securities in Issue
- Warner Chilcott Announces Decision in Doryx Patent Litigation
- NASDAQ 100 Worst Performer: Netflix
- Warner Chilcott Higher With High Volume
Related Partner Headlines
- UPDATE: Canaccord Genuity Raises Warner Chilcott's PT - Benzinga
- Option Activity Could Signal Imminent Warner Chilcott Deal - Benzinga
- Bank of America: Warner Chilcott's Theoretical Value Higher than Standalone Target - Benzinga
- UPDATE: Cantor Fitzgerald Raises its PT on Warner Chilcott - Benzinga
- Warner Chilcott Says Court Upheld Patent Validity in Doryx Patent Case - Benzinga
- Warner Chilcott Stock Gaps Up On Today's Open (WCRX) - TheStreet.com
- Warner Chilcott: Review of Strategic Alternatives - Benzinga
- Warner Chilcott Rises On Unusually High Volume (WCRX) - TheStreet.com
- Warner Chilcott PLC Stock Upgraded (WCRX) - TheStreet.com
- UPDATE: Goldman Sachs Lowers PT to $20 on Warner Chilcott - Benzinga
JIM CRAMER wants to work for YOU. JIM does the research -- YOU get email alerts each time he trades. JIM provides access to his actual portfolio -- YOU can use it to guide your portfolio strategy.
Try Jim's Action Alerts PLUS for FREE!
TradersHuddle Search
| Sponsored By:
|
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
Stock Market
Loading
